Holen Sie sich die Stockscreener-App
21.79
7.39%
-1.74
Vorhandelsmarkt:
21.84
0.05
+0.23%
Schlusskurs vom Vortag:
$23.53
Offen:
$23.05
24-Stunden-Volumen:
18.28M
Relative Volume:
1.41
Marktkapitalisierung:
$4.76B
Einnahmen:
$1.24B
Nettoeinkommen (Verlust:
$101.26M
KGV:
-128.18
EPS:
-0.17
Netto-Cashflow:
$149.62M
1W Leistung:
-21.05%
1M Leistung:
-1.63%
6M Leistung:
+17.15%
1J Leistung:
+181.52%
1-Tages-Spanne:
$21.44
$23.12
1-Wochen-Bereich:
$19.15
$25.45
52-Wochen-Spanne:
$7.505
$30.44
Hims Hers Health Inc Stock (HIMS) Company Profile
Firmenname
Hims Hers Health Inc
Sektor
Telefon
415-851-0195
Adresse
2269 CHESTNUT ST, SAN FRANCISCO
Vergleichen Sie HIMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| HIMS | 21.79 | 4.76B | 1.24B | 101.26M | 149.62M | -0.17 |
| PG | 170.89 | 401.37B | 83.91B | 14.32B | 15.85B | 6.16 |
| UL | 57.55 | 143.21B | 64.93B | 7.15B | 0 | 3.4285 |
| CL | 93.91 | 76.48B | 20.11B | 2.87B | 3.40B | 1.92 |
| KVUE | 23.78 | 45.59B | 15.46B | 1.06B | 1.40B | 0.496 |
| KMB | 136.37 | 45.48B | 20.10B | 2.61B | 2.90B | 5.20 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-28 | Eingeleitet | TD Cowen | Outperform |
| 2023-04-11 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-02-09 | Hochstufung | Jefferies | Hold → Buy |
| 2022-11-08 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-08 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-07-15 | Eingeleitet | SVB Leerink | Underperform |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-10 | Eingeleitet | Deutsche Bank | Hold |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-11-11 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | Eingeleitet | BofA Securities | Neutral |
| 2021-05-20 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | Eingeleitet | Truist | Hold |
| 2021-03-09 | Eingeleitet | Credit Suisse | Neutral |
| 2021-03-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-02-17 | Eingeleitet | Citigroup | Neutral |
| 2021-02-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-02-08 | Eingeleitet | Tigress Financial | Buy |
Alle ansehen
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Principal Financial Group Inc. Has $5.35 Million Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Amazon's push into telehealth knocks shares of Hims & Hers - MSN
Amazon Sets Sights on Both Hims & Hers and Temu. Is This a Golden Opportunity to Buy the Stock? - AOL
Amazon Sets Sights on Both Hims & Hers and Temu. Is This a Golden Opportunity to Buy the Stock? - The Motley Fool
Hims & Hers stock falls as Amazon launches Telehealth offering - MSN
Will Amazon Bury Hims Stock or Should You Buy the Dip? - Yahoo Finance
Hims & Hers Health: Far From Dead, Even With Amazon's Threat Ahead (NYSE:HIMS) - Seeking Alpha
TD Cowen reaffirms Buy rating on Hims and Hers stock, highlights FDA case impact - Investing.com
Connor Clark & Lunn Investment Management Ltd. Lowers Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers Stock Gains 31.1% Since Q3 Earnings: What's Next? - MSN
Hims & Hers health chief commercial officer sells $165,000 in stock - Investing.com
hims & hers COO Melissa Baird sells shares worth $1.24 million - Investing.com
Hims & Hers Health (NYSE:HIMS) Shares Gap DownShould You Sell? - MarketBeat
Hims & Hers Health Inc (HIMS) Trading 8.64% Higher on Nov 19 - GuruFocus.com
Hims & Hers stock (HIMS) drops 24% after Amazon telehealth announcement—here's why - InvestorsObserver
Hims & Hers Stock Climbs After Former Regulator Autor Joins Board - Marketscreener.com
Unpacking the Latest Options Trading Trends in Hims & Hers Health - Benzinga
Hims & Hers Stock Tumbles Amid Amazon Telehealth Push - AskTraders
Price Over Earnings Overview: Hims & Hers Health - Benzinga
Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions - BioSpace
Hims & Hers Bolsters Leadership with Former FDA Commissioner, Quality Expert | HIMS Stock News - StockTitan
Royce & Associates LP Increases Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory - Insider Monkey
Should You Buy Hims & Hers Stock On The Dip? - Barchart
Amazon.com Inc (AMZN-Q) QuotePress Release - The Globe and Mail
Hims & Hers Stock Is Down 30% This Week: Here's What Happened - AOL
Insider Sale: Director David Wells Sells 40,000 Shares of Hims & Hers Health Inc (HIMS) - GuruFocus.com
Should You Buy Hims & Hers Stock on the Dip? - Nasdaq
Hims & Hers: Revolutionizing Telehealth And Captivating InvestorsHere's Why You Should Buy - Seeking Alpha
Hims & Hers Health: The Amazon Curse Is Being Overstated (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health Insider Trades Send A Signal - Benzinga
Hims Drops Most Ever as Amazon Enters Hair-Loss Drug Market - The Business of Fashion
Hims & Hers Shares Drop Following Amazon's Expansion into Telehe - GuruFocus.com
Hims & Hers Shares Drop Following Amazon's Expansion into Telehealth - Yahoo Finance
State of New Jersey Common Pension Fund D Has $2.28 Million Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Director Anja Manuel Acquires 5,000 Shares of Hims & Hers Health Inc (HIMS) - GuruFocus.com
Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments - The Wall Street Journal
Hims & hers director Manuel Anja acquires $132,259 in stock - Investing.com
Hims & Hers health CFO sells shares worth $4.28 million - Investing.com
Hims & Hers director David Wells sells $1.2 million in stock - Investing.com
Hims & Hers’ stock tumbles on Amazon’s latest disruptive foray into healthcare - MSN
Notable Thursday Option Activity: HIMS, PAG, SNOW - Nasdaq
BofA cuts Hims & Hers rating on Amazon market entry - Investing.com
BofA cuts Hims & Hers rating on Amazon market entry By Investing.com - Investing.com Australia
Hims & Hers Stock’s Retail Army Brushes Off Amazon Medical One’s Rival Service Even As Citi Sees Threat - MSN
Hims & Hers stock tanks as Amazon debuts fixed pricing for hair-loss and erectile-dysfunction drugs - Fast Company
Amazon to Sell Cheap Hair-Loss Drugs. It’s a Big Threat for Hims & Hers Stock. - Barron's
Hims & Hers cut to underperform by BoA over Amazon competition (NYSE:HIMS) - Seeking Alpha
Amazon launches lifestyle drug service as challenge to Hims & Hers - Yahoo Finance
Amazon Challenges Telehealth With New Affordable Service - Finimize
Finanzdaten der Hims Hers Health Inc-Aktie (HIMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.71%
2.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):